Congress of psychiatry
Download 0.5 Mb. Pdf ko'rish
|
A Y SCIENTIFIC PROGRAMME 136 003 Neurohistological evidence of brain inflamma- tion in psychotic and affective disorders Bernhard Bogerts, Germany 004 Infections and inflammation as possible causes of severe mental disorders – findings from large scale studies Michael Benros, Denmark S-152 Symposium 10:00 – 11:30 | Hall London 1 TOPIC 31: Suicide and psychiatric emergencies Suicide prevention at the national and international level Chairs: Ulrich Hegerl, Germany Zul Merali, Canada 001 International suicide prevention approaches: the European Alliance Against Depression Ulrich Hegerl, Germany 002 National suicide prevention approaches in Canada Edward Mantler, Canada 003 National suicide prevention approaches in the Netherlands Jan K. Mokkenstorm, The Netherlands 004 National suicide prevention approaches in Spain Victor Pérez Sola, Spain S-153 Symposium 10:00 – 11:30 | Room M4 / M5 TOPIC 22: Community and social psychiatry Primary health care for patients with affective disor- ders: comparison of different European countries Chairs: Detlef E. Dietrich, Germany Vincenzo Costigliola, Belgium 001 GP: first drug – primary health care of patients with affective disorders in Europe from a Belgium perspective Vincenzo Costigliola, Belgium 002 Primary care and management of affective disorders in Spain Juan Mendive, Spain 003 German primary health care approaches to affective disorders Jochen Gensichen, Germany S-154 Symposium 10:00 – 11:30 | Room Weimar 3 TOPIC 5: Neurotic, stress-related and somatoform disorders Epigenetic mechanisms of fear and anxiety in mice and men: DNA methylation, histone acetylation and microRNAs Chairs: Jürgen Deckert, Germany Katharina Domschke, Germany 001 Developmental epigenetic programming by prenatal maternal stress Daniel van den Hove, The Netherlands Magdalena Weidner, Karla-Gerlinde Schraut, Angelika Schmitt, Klaus-Peter Lesch 002 MicroRNAs as epigenetic mechanisms in fear learning and anxiety Leif Hommers, Germany 003 MicroRNAs and histone acetylation as epigene- tic mechanisms in fear extinction and anxiety Nicolas Singewald, Austria 004 DNA methylation as epigenetic mechanism in panic disorder and social phobia Christiane Ziegler, Germany Udo Dannlowski, David Bräuer, Marina Mahr, Agnieszka Gajewska, Miriam A. Schiele, Leonie Kollert, Jürgen Hoyer, Alexander Gerlach, Volker Arolt, Peter Zwanzger, Jürgen Deckert, Katharina Domschke S-155 Symposium 10:00 – 11:30 | Room M6 TOPIC 21: Rehabilitation and work Psychiatric rehabilitation – the basis for inclusion › WPA Section: Psychiatric Rehabilitation Chairs: Johannes Wancata, Austria Pichet Udomratn, Thailand 001 Psychiatric rehabilitation in Asia – an experi- ence from Thailand Pichet Udomratn, Thailand 002 From the linear continuum approach to sup- ported inclusion: a paradigm shift for psychiatric rehabilitation Dirk Richter, Switzerland Holger Hoffmann 003 Does competitive work increase mental health in patients with severe mental illness? Holger Hoffmann, Switzerland 004 Mothers and fathers of schizophrenia patients Johannes Wancata, Austria MOND A Y TUESD A Y WEDNESD A Y THURSD A Y German language Session Q & A Modul SCIENTIFIC PROGRAMME 137 S-156 Symposium 10:00 – 11:30 | Room Weimar 1 TOPIC 19: Stimulation methods and interdisciplinary interventions Electroconvulsive therapy (ECT) in the elderly: an update on clinical practice and latest research data Chairs: Georgios Petrides, USA Pascal Sienaert, Belgium 001 Effects of a right unilateral ultrabrief pulse electroconvulsive therapy course on health related quality of life in elderly depressed patients Vaughn McCall, USA 002 Long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly patients Pascal Sienaert, Belgium 003 Electroconvulsive therapy for severe agitation in Alzheimer's dementia Brent Forester, USA 004 The mortality rate of electroconvulsive therapy (ECT): a systematic review and pooled analysis Søren Dinesen Østergaard, Denmark S-157 Symposium 10:00 – 11:30 | Room Lindau 3 TOPIC 25: Training and continuing education Excerpts from German psychiatric teaching › DGPPN Section: Universitäre Lehre Chairs: Jörg Signerski-Krieger, Germany Peter Goll, Germany 001 Learning by playing Franziska Baessler, Germany 002 Imparting empathy during bedside teaching Gottfried Maria Barth, Germany 003 Use of actors as patients in bedside teaching Philipp Spitzer, Germany 004 Different test forms, in particular OSCE stations Daniela Roesch Ely, Germany Franziska Bässler, Jan Lauter S-158 Symposium 10:00 – 11:30 | Room Lindau 6 TOPIC 34: Psychiatry in developing regions Joint symposium of the Mozambican association of psychiatry and mental health and Portuguese society of psychiatry and mental health Chairs: Lidia Gouveia, Portugal Antonio Pacheco Palha, Portugal 001 Diagnostic stability of psychiatric disorders in clinical practice – a retrospective study Anibal Anube, Mozambique 002 Burnout in informal caregivers of patients with psychiatric disorders Rogério Mulumba, Mozambique 003 Metabolic syndrome in inpatient with schizo- phrenia and major depressive disorder – a case study in Casa de Saúde do Bom Jesus Domingas Ferrão, Mozambique 004 My experience in the implementation of a postgraduate program for Mozambique residents in psychiatry in Oporto and Minho Universities Antonio Pacheco Palha, Portugal S-159 Symposium 10:00 – 11:30 | Room Dessau 6 TOPIC 3: Psychotic disorders STEPWISE: structured lifestyle education for people with schizophrenia trial Chairs: Richard Holt, United Kingdom Shanaya Rathod, United Kingdom 001 Background and methodology of the STEPWISE trial Paul French, United Kingdom Richard Holt, Shanaya Rathod, Rebecca Gossage-Worrall 002 Main results of the STEPWISE trial Richard Holt, United Kingdom 003 Process evaluation of the STEPWISE lifestyle education programme Rebecca Gossage-Worrall, United Kingdom 004 Implications of the trial for weight manage- ment of people with severe mental illness Shanaya Rathod, United Kingdom MOND A Y TUESD A Y WEDNESD A Y THURSD A Y SCIENTIFIC PROGRAMME 138 S-037 (d) Symposium (German) 10:00 – 11:30 | Hall A1 TOPIC 9: Comorbidity of somatic and mental disorders, psychosomatics Grundlagen und Behandlung von chronischem Schmerz › DGPPN Section: Psychosomatik Chairs: Manfred Fichter, Germany Walter Zieglgänsberger, Germany 001 Fehlgeschlagene multimodale Therapieversu- che wirken als Nocebo Walter Zieglgänsberger, Germany 002 Untersuchungen zu Placebo- / Noceboeffekten Ulrike Bingel, Germany 003 Neueste Maxime empirisch fundierter psycho- logischer Behandlung und Präventionsmaßnahmen bei chronischen Schmerzsyndromen Winfried Rief, Germany S-038 (d) Symposium (German) 10:00 – 11:30 | Hall London 3 TOPIC 2: Mental disorders due to psychotropic substances, behavioural addictions Crystal Meth – Update 2017: aktuelle Präventions- und Therapieangebote in Sachsen › SWGN – Sächsische Wissenschaftliche Gesellschaft für Nervenheilkunde e.V. Chairs: Thomas Barth, Germany Michael Bauer, Germany 001 Methamphetaminabhängigkeit – Behandlungs- bedarf und -optionen in Sachsen Niels Bergemann, Germany 002 Schwangerschaft und Crystal Meth – Angebote für substanzabhängige werdende Eltern Ulrich Zimmermann, Germany Jörg Reichert, Jürgen Dinger, Katharina Nitzsche, Kristin Ferse 003 Qualitätsmessung und Vergütung stationärer Suchtbehandlung bei Polytoxikomanie Thomas Barth, Germany Brigitte Sandy Voigtländer 004 Qualifizierte Entgiftung von Alkohol sowie Methamphetamin auf einer gemeinsamen Station für Abhängigkeitserkrankungen Thomas Reuster, Germany S-039 (d) Symposium (German) 10:00 – 11:30 | Hall London 2 TOPIC 31: Suicide and psychiatric emergencies Suizidalität – biologisch betrachtet Chairs: Dan Rujescu, Germany Ute Lewitzka, Germany 001 Ist Suizidalität vererbbar? Zur Genetik suizida- len Verhaltens Dan Rujescu, Germany 002 Biologische Risikoparameter für Suizidalität bei Kindern und Jugendlichen mit affektiven Erkrankun- gen – was wissen wir heute? Ute Lewitzka, Germany 003 Psychopharmakotherapie: Suizidprävention oder Suizidpromotion? Thomas Bronisch, Germany 004 Lithium und andere mood stabilizer in der Suizidprävention Robert Haußmann, Germany S-040 (d) Symposium (German) 10:00 – 11:30 | Hall New York 2 TOPIC 32: Violence and trauma DGPPN S3-Leitlinie Verhinderung von Zwang: therapeutische Maßnahmen bei aggressivem Verhalten Chairs: Tilman Steinert, Germany Tanja Henking, Germany 001 Reduktion von Zwang: Ergebnisse eines systematischen Reviews Sophie Hirsch, Germany 002 Rechtliche und ethische Aspekte Tanja Henking, Germany 003 Beziehung und Pflege André Nienaber, Germany 004 Von der Evidenz zur Empfehlung Tilman Steinert, Germany Sophie Hirsch MOND A Y TUESD A Y WEDNESD A Y THURSD A Y German language Session Q & A Modul SCIENTIFIC PROGRAMME 139 S-041 (d) Symposium (German) 10:00 – 11:30 | Room M1 TOPIC 1: Neurocognitive disorders, organic mental disorders, dementia Kognitive Dysfunktion und Delir bei Älteren in einer hochtechnisierten medizinischen Welt: Prävention und Management Chairs: Gerhard W. Eschweiler, Germany Christine Thomas, Germany 001 Prävalenz und Inzidenz von perioperativem Delir und postoperativer kognitiver Dysfunktion (POCD) bei älteren Menschen Michael Rapp, Germany 002 Klinische und psychosoziale Risikofaktoren für die Entwicklung eines Delirs und POCD Gerhard W. Eschweiler, Germany 003 Perioperative Delirprävention und -manage- ment: Wunsch und Wirklichkeit Christine Thomas, Germany S-042 (d) Symposium (German) 10:00 – 11:30 | Room M8 TOPIC 22: Community and social psychiatry Wirkt Home Treatment auch in der deutsch- sprachigen psychiatrischen Versorgung? Empirische Daten aus dem deutschsprachigen Raum Chairs: Andreas Bechdolf, Germany Jürgen Gallinat, Germany 001 Langzeitergebnisse von Assertive Community Treatment bei jugendlichen und erwachsenen Patienten mit schweren psychotischen Störungen Martin Lambert, Germany 002 Kognitive Verhaltenstherapie und Assertive Community Treatment zur Prävention von stationä- ren Aufenthalten Andreas Bechdolf, Germany Ines Haag, Christian Konkol, Frank Jessen, Eun-Hae Kim, Hendrik Müller, Johanna Klaus 003 Home Treatment bei akuten psychiatrischen Erkrankungen: Effektivness in der Regelversorgung Urs Hepp, Switzerland Lea Wyder, Niklaus Stulz 004 Stationsersetzende Behandlung im Brennpunkt Großstadt: Evaluationsergebnisse eines Modellpro- jektes gem. § 64b SGB V Felix Bermpohl, Germany C. Montag, A. Matthey, Z. Strasser, T. Kaiser, A. Wullschleger, J. Berg, N. Schoofs S-043 (d) Symposium (German) 10:00 – 11:30 | Room R2 TOPIC 27: Religion and spirituality Spiritus contra Spiritum? Die Rolle der Spiritua- lität bei Suchterkrankungen Chairs: Jürgen Hoß, Germany Human-Friedrich Unterrainer, Austria 001 Spiritualität bei den Anonymen Alkoholikern aus der Sicht eines evangelischen Christen Frithjof Sahnwaldt, Germany 002 Die Rolle der Spiritualität in der Behandlung von Suchterkrankungen Human-Friedrich Unterrainer, Austria 003 Spiritualität und Religion aus der Sicht eines AA-Mitglieds – ein Erfahrungsbericht Andrew, Germany WS-13 Workshop 10:00 – 11:30 | Room Weimar 5 TOPIC 15: Cross-disorder mechanisms and principles Relevance of e-mental health for today's mandate of psychiatry Chairs: Reinhard Michael Krausz, Canada Frances Kay-Lambkin, Australia Speaker: Anil Thapliyal, New Zealand WS-14 Workshop 10:00 – 11:30 | Room Dessau 3 TOPIC 25: Training and continuing education International medical graduates – effective supervision – how essential is it? Chairs: Raja Natarajan, United Kingdom Janet Allison, United Kingdom Speakers: Raja Natarajan, United Kingdom Marilia Calcia, United Kingdom OS-24 Oral Presentation Session 10:00 – 11:30 | Room R3 TOPIC 12: Epidemiology and risk factors Epidemiology and risk factors III Chairs: Elie Karam, Lebanon Jens Wiltfang, Germany 001 Various psychiatric disorders among the female victims of domestic violence (DV) – a cross sectional study from India Supriya Agarwal, India Sandeep Antil, S. Sudarsanan, Sandeep Choudhary MOND A Y TUESD A Y WEDNESD A Y THURSD A Y SCIENTIFIC PROGRAMME 140 002 Australian private psychiatry as governmentally funded considered in terms of social equity Graham Meadows, Australia Joanne Enticott, Grant Russell, Brett Inder, Roger Gurr, Frances Shawyer, Scott Pattern 003 Use of high H1 receptor affinity antidepressants and risk of type 2 diabetes mellitus Virginio Salvi, Italy Francesco Barone-Adesi, Roberta Picariello, Tiziana Cena, Corrado Magnani, Fabrizio Faggiano, Claudio Mencacci, Roberto Gnavi, Giuseppe Costa 004 Measuring and correlating autistic characteris- tics and coping mechanisms – a study involving 1714 members of Portuguese universities Eduardo Jorge Palha Teixeira Fernandes, Portugal Patrick Alves, Cristina Sousa 005 Risk factors associated with behavioral / emotional problems of preschoolers in a low-income community Marina Monzani Da Rocha, Brazil Cibelle A. de la Higuera Amato, Alessandra Laranjeira Oddone, Gabriela Zanata Pinheiro OS-25 Oral Presentation Session 10:00 – 11:30 | Room R13 TOPIC 6: Eating disorders, sleep disorders and other disorders of this category Eating disorders and related symptoms Chairs: Palmiero Monteleone, Italy Beate Herpertz-Dahlmann, Germany 002 A systematic review of pro- and anti-inflamma- tory cytokines in eating disorders Bethan Dalton, United Kingdom Savani Bartholdy, Gerome Breen, Mohammad A. A. Ibrahim, Ulrike Schmidt, Hubertus Himmerich 003 Intranasal oxytocin in the treatment of anorex- ia nervosa – a randomized placebo-controlled trial of hospitalised patients during re-feeding Sarah Maguire, Australia Janice Russell, Alice Kesby, Glenn Hunt, Iain McGregor 004 Subtypes of personality and “locus of control” in bariatric patients and their effect on weight loss, eating disorder, depressive symptoms and quality of life Carolin Peterhänsel, Germany Katja Linde, Birgit Wagner, Arne Dietrich, Anette Kersting OS-26 (d) Oral Presentation Session 10:00 – 11:30 | Room R12 TOPIC 22: Community and social psychiatry Versorgungsmodelle und Behandlungskonzepte II Chairs: Christa Roth-Sackenheim, Germany Christian Kieser, Germany 001 Ärztenetze nach § 87b SGB V und ambulante Komplexbehandlung – neue Chancen für die sektor- übergreifende psychiatrische Versorgung Norbert Mönter, Germany; Carsten Jäger 002 Neues Therapiekonzept zur Erststabilisierung und Arousalmodulation für stark belastete Kinder und Jugendliche und minderjährige Flüchtlinge: START – Stress-Traumasymptoms-Arousal- Regulation-Treatment Andrea Dixius, Germany; Eva Möhler 003 Wie entwickelten sich chronisch psychisch erkrankte Menschen im Rahmen gemeindepsychi- atrischer Versorgungsangebote? Ergebnisse einer Längsschnittstudie unter Empfängern ambulanter Eingliederungshilfeleistungen in Norddeutschland Johanna Baumgardt, Germany; Dieter Röh 004 Die Einbeziehung von Angehörigen in die psy- chiatrisch-psychotherapeutische Therapie aus Sicht der professionellen Helfer Isabel Maurus, Germany Josef Bäuml, Gabriele Pitschel-Walz, Sandra Lüscher 005 Fast 2 Jahre Genesungsbegleitung auf der geschlossenen Akutstation im UKE in Hamburg – Erfahrungen, Erlebnisse und meine subjektive Sicht, auch bei Zwang: Ideen für eine zukunftsweisende, andere Akutpsychiatrie Stefanie Böttger, Germany PC-07 Pro-Con-Debate 10:30 – 11:30 | Hall A8 TOPIC 31: Suicide and psychiatric emergencies Suicide can be prevented by psychiatrists Chairs: Fritz Hohagen, Germany Pavel Alfimov, Russia Proponent: Maria A. Oquendo, USA Opponent: Michael Davidson, Israel KN-15 Keynote Lecture 11:45 – 12:45 | Hall B TOPIC 35: Psychiatry and society Cross-cultural values, social identity and resilience: how to cope with mental challenges of migration Chairs: Laurence J. Kirmayer, Canada Fritz Hohagen, Germany Speaker: Martin Bohus, Germany MOND A Y TUESD A Y WEDNESD A Y THURSD A Y German language Session Q & A Modul SCIENTIFIC PROGRAMME 141 KN-16-PF Keynote Lecture 11:45 – 13:00 | Hall A3 TOPIC 23: Health care research and models, health care policy Download 0.5 Mb. Do'stlaringiz bilan baham: |
Ma'lumotlar bazasi mualliflik huquqi bilan himoyalangan ©fayllar.org 2024
ma'muriyatiga murojaat qiling
ma'muriyatiga murojaat qiling